DexCom Reports Strong Q1 Revenue Growth Amid Stock Decline

Despite a challenging stock performance over the past year and in 2026, DexCom reported better-than-expected first-quarter revenue growth driven by global adoption of its CGM systems. The company's shares rose slightly following the earnings announcement.

By Kritika Sarmah Fri, May 15, 2026 at 2:42 PM GMT+3 2 min read · Yahoo Finance · May 15, 2026, 11:42 UTC

DexCom Reports Strong Q1 Revenue Growth Amid Stock Decline

Tickers: $DXCM $XLV

Topics: continuous glucose monitoring (CGM) DexCom medical technology stock performance

Read the full article at Yahoo Finance

More World news

Donald Trump Suggests Tim Cook as Potential Successor for Nvidia Following Jensen Huang's Resignation The Verge · November 12, 2026, 16:09 UTC
Yankees President Randy Levine Advocates for Protect College Sports Act and Addresses MLB Labor Uncertainty CNBC · November 12, 2026, 15:34 UTC
Donald Trump Suggests Apple Chairman Tim Cook as Potential Successor to Nvidia CEO Jensen Huang TechCrunch · November 12, 2026, 16:12 UTC
Bybit Announces Title Partnership for Inaugural Stockholm Open ATP 250 Tournament PR Newswire · November 12, 2026, 16:11 UTC
SES AI Reports Q3 2026 Revenue Growth Amid Strategic Shift Toward Drone Battery Market Motley Fool · November 12, 2026, 16:10 UTC
Nvidia Shares Decline Following Resignation of CEO Jensen Huang Seeking Alpha · November 12, 2026, 16:07 UTC
Broadcom and Micron Identified as Top Alternatives to Nvidia Amid Leadership Uncertainty Motley Fool · November 12, 2026, 16:03 UTC
Thomson Reuters Executives to Present at TD Securities Technology Conference PR Newswire · November 12, 2026, 16:00 UTC
BHP to Restructure Australian Iron Ore Operations Amid Rising Costs Seeking Alpha · November 12, 2026, 15:59 UTC
Capri Investment Group and GRIT Chicago Unveil $10 Billion Bronzeville Lakefront Development Plan PR Newswire · November 12, 2026, 16:00 UTC